Postoperative prostate-specific antigen nadir improves accuracy for predicting biochemical recurrence after radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital (SEARCH) and Duke Prostate Center databases-Reference-Cited by-同舟云学术

Postoperative prostate-specific antigen nadir improves accuracy for predicting biochemical recurrence after radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital (SEARCH) and Duke Prostate Center databases

Published:2010-09-30 Issue:11 Volume:17 Page:914-922
ISSN:0919-8172
Container-title:International Journal of Urology
language:en
Short-container-title:

Author:

Moreira Daniel M,Presti Jr Joseph C,Aronson William J,Terris Martha K,Kane Christopher J,Amling Christopher L,Sun Leon L,Moul Judd W,Freedland Stephen J

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1442-2042.2010.02631.x/fullpdf

Reference30 articles.

1. Surgeon experience is strongly associated with biochemical recurrence after radical prostatectomy for all preoperative risk categories;Klein;J. Urol.,2008

2. Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy;Freedland;JAMA,2005

3. Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial;Thompson;JAMA,2006

4. Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95;Wiegel;J. Clin. Oncol.,2009

5. Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911);Bolla;Lancet,2005

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate-Specific Antigen as an Ultrasensitive Biomarker for Patients with Early Recurrent Prostate Cancer: How Low Shall We Go? A Systematic Review;Biomedicines;2024-04-08

2. Prediction of biochemical failure using prostate-specific antigen half-life in patients with adverse pathologic features after radical prostatectomy;World Journal of Urology;2018-10-22

3. Stratification model based on early postprostatectomy prostate-specific antigen kinetics may help to reduce the risk of overtreatment in candidates for adjuvant radiotherapy;Scandinavian Journal of Urology;2017-02-24

4. Adverse pathology and undetectable ultrasensitive prostate-specific antigen after radical prostatectomy: is adjuvant radiation warranted?;BJU International;2015-06-23

5. Adjuvant and Salvage Radiotherapy After Prostatectomy: American Society of Clinical Oncology Clinical Practice Guideline Endorsement;Journal of Clinical Oncology;2014-12-01